1. European Medicines
Agency (EMA), Committee for Medicinal
Products for Human Use (CHMP) (2013) Reflection paper on the data requirements for intravenous
liposomal products developed with reference to an innovator liposomal
product, European Medicines Agency.
2. Food and Drug Administration (FDA),
Office of Generic Drugs (2012) Draft guidance on paclitaxel, Food and Drug Administration.
3. European Medicines Agency (EMA), Committee for Medicinal
Products for Human Use (CHMP) (2013) Joint MHLW/EMA reflection paper on the development of block
copolymer micelle medicinal products, European
Medicines Agency.
4. Food
and Drug Administration (FDA), Office of Generic Drugs (2013) Draft guidance on doxorubicin
hydrochloride, Food and Drug Administration.
5. Food and Drug Administration (FDA) (2014) Draft guidance on daunorubicin
citrate, Food and Drug Administration